Comparison of Viscum album QuFrF extract with vincristine in an in vitro model of human B cell lymphoma WSU-1

Arzneimittel-Forschung/Drug Research

Volumn 58, Issue 11, 2008, Pages 592-597

  Kovacs, Eva ^a,b   Link, Susanne ^a   Toffol Schmidt, Ulrike ^a  

^a Society for Cancer Research   (Switzerland)

^b Hiscia Institute   (Switzerland)

Author keywords

B cell lymphoma cells, apoptosis, necrosis, WSU 1 cell line; CAS 57 22 7; Chemotherapeutics; Iscador ; Vincristine; Viscum album L. QuFrF extract, human B cell lymphoma, in vitro studies

Indexed keywords

INTERLEUKIN 6; LECTIN; VINCRISTINE SULFATE; VISCUM ALBUM EXTRACT;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA SYNTHESIS; DRUG EFFECT; HUMAN; HUMAN CELL; IN VITRO STUDY;

EID: 57649136645     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296562     Document Type: Article

References (15)

1. Kovacs E, Link S, Toffol-Schmidt U. Cytostatic and cytocidal effects of mistletoe (Viscum album L.) Quercus extract Iscador. Arzneimittel- Forschung (Drug Research). 2006;56:467-473.
2. Kovacs E. How does interleukin-6 affect the membrane expression of interleukin-6 receptor and gp130 and the proliferation of the human myeloma cell line OPM-2? Biomed Pharmacother. 2003;57:489-494.
3. Mastberger SC, Duivenvoorden I, Versteegh RT, Geldof AA. Cell cycle arrest and clonogenic tumour cell kill by divergent chemotherapeutic drugs. Anticancer Res. 2000;20:1833-1838.
4. El Alaoui S, Lawry J, Griffan M. The cell cycle and induction of apoptosis in a hamster fibrosarcoma cell line treated with anti-cancer drugs: its importance to solid tumour chemotherapy. J Neurol. 1997;31:195-207.
5. Urech K, Buessing A, Thalmann G, Schaefermeyer H, Heusser P. Antiproliferative effects of mistletoe (Viscum album L) extract in urinary bladder carcinoma cell lines. Anticancer Res. 2006;26:3049-3056.
6. Maier G, Fiebig HH. Absence of tumour growth stimulation in a Panel of 16 human tumour cell lines by mistletoe extracts in vitro. Anticancer Drugs. 2002;13:373-379.
7. Kelter G, Fiebig, HH. Absence of tumour growth stimulation in a Panel of 26 human tumour cell lines by mistletoe (Viscum album L) extracts Iscador in vitro. Arzneimittel-Forschung (Drug Research). 2006;56:435-440.
8. Stokke T, Smeland EB, Kvaloy S, Holte H. Tumour proliferation, but not apoptosis, predicts survival in B-cell non-Hodgkin's lymphomas. Br J Cancer. 1998;77:1839-1841.
9. R Qu an cell cycle progression and apoptosis in cancer cells. Int J Oncol. 2004;125:1521-1529.
10. Cohen JJ. Apoptosis. Immunol Today. 1993;14:123-130
11. Leoncini L, Vecchio MTD, Megha T, Barbini P, Galieni P, Pileri S, et al. Correlation between apoptotic and proliferative indices in malignant non-Hodgkin's lymphoma. Am J Pathol. 1993;142:755-762.
12. Stokke T, Holte H, Smedshammer L, Smeland EB, Kaalhus O, Steen HB. Proliferation and apoptosis in malignant and normal cells in B-cell non-Hodgkin's lymphomas. Br J Cancer. 1998;77:1832-1838.
13. Kovacs E. Multiple myeloma and B cell lymphoma. Investigation of IL-6, IL-6 receptor antagonist (IL-6RA) and gp130 antagonist (gp130A) using various parameters in an in vitro model. Sci World J. 2006;6:888-898.
14. Lin CK, Nguyen TT, Morgan TL, Mei RL, Kaptein JS, Kalunta CI, et al. Apoptosis may be either suppressed or enhanced with strategic combinations of antineoplastic drugs or anti-IgM. Exp Cell Res. 1998;244:1-13.
15. Wheeler RH, Clauw DJ, O'Toole TE, Ensminger WD. Cytokinetic evaluation of the four drug combination of Bleomycin, vincristine, Mitomycin C and Methotrexate in cultured Burkitt's lymphoma cells and human bone marrow. Cancer. 1982;50:1993-1999.